NCT00947167 2017-03-03A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine TumorsStanford UniversityPhase 2 Terminated4 enrolled 5 charts
NCT00997594 2015-04-28Changes in Adrenal Hormones During Adrenal Radiofrequency AblationMie UniversityPhase 2/3 Completed18 enrolled 6 charts